Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of KALV
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

KalVista Pharmaceuticals Inc stock downgraded to Hold/Accumulate
(Updated on May 10, 2024)

Buy or Hold candidate since May 01, 2024 Loss -0.82% PDF

The KalVista Pharmaceuticals Inc stock price fell by -0.0827% on the last day (Friday, 10th May 2024) from $12.09 to $12.08. During the last trading day the stock fluctuated 2.97% from a day low at $11.79 to a day high of $12.14. The price has risen in 6 of the last 10 days and is up by 12.06% over the past 2 weeks. Volume has increased on the last day by 85 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 211 thousand shares were bought and sold for approximately $2.55 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -20.02% during the next 3 months and, with a 90% probability hold a price between $7.78 and $10.26 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

KALV Signals & Forecast

The KalVista Pharmaceuticals Inc stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $12.12. On a fall, the stock will find some support from the long-term average at approximately $11.54. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. A buy signal was issued from a pivot bottom point on Wednesday, April 24, 2024, and so far it has risen 16.71%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for KalVista Pharmaceuticals Inc stock

KalVista Pharmaceuticals Inc finds support from accumulated volume at $11.93 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.350 between high and low, or 2.97%. For the last week, the stock has had daily average volatility of 2.23%.

Our recommended stop-loss: $11.74 (-2.80%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 12 days ago.)

Trading Expectations (KALV) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect KalVista Pharmaceuticals Inc to open at $12.00, and during the day (based on 14 day Average True Range), to move between $11.57 and $12.59, which gives a possible trading interval of +/-$0.505 (+/-4.18%) up or down from last closing price. If KalVista Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 8.37% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $11.93 (1.24%) than the resistance at $12.58 (4.14%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is KalVista Pharmaceuticals Inc stock A Buy?

KalVista Pharmaceuticals Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: -0.277 Hold/Accumulate Downgraded

Predicted Opening Price for KalVista Pharmaceuticals Inc of Monday, May 13, 2024

Fair opening price May 13, 2024 Current price
$12.00 ( 0.635%) $12.08

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for KALV

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 12.35 2.26 %
R2 12.22 1.16 %
R1 12.14 0.472 %
Current price: 12.08
Support S1 11.87 -1.74 %
S2 11.79 -2.43 %
S3 11.65 -3.53 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 14.85 22.93 %
R2 14.76 22.19 %
R1 12.58 4.14 %
Current price 12.08
Support S1 11.93 -1.24%
S2 11.86 -1.82%
S3 11.04 -8.61%

FAQ

What is the symbol for KalVista Pharmaceuticals Inc Stock and on which exchange is it traded?
The symbol for KalVista Pharmaceuticals Inc is KALV and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell KalVista Pharmaceuticals Inc Stock?
KalVista Pharmaceuticals Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

How to buy KalVista Pharmaceuticals Inc Stock?
KalVista Pharmaceuticals Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy KalVista Pharmaceuticals Inc Stock.

What's the current price of KalVista Pharmaceuticals Inc Stock?
As of the end of day on the May 10, 2024, the price of an KalVista Pharmaceuticals Inc (KALV) share was $12.08.

What is the 52-week high and low for KalVista Pharmaceuticals Inc Stock?
The 52-week high for KalVista Pharmaceuticals Inc Stock is $16.88 and the 52-week low is $7.21.

What is the market capitalization of KalVista Pharmaceuticals Inc Stock?
As of the May 10, 2024, the market capitalization of KalVista Pharmaceuticals Inc is 509.635M.

When is the next earnings date for KalVista Pharmaceuticals Inc?
The upcoming earnings date for KalVista Pharmaceuticals Inc is Jul 05, 2024.
Click to get the best stock tips daily for free!

About KalVista Pharmaceuticals Inc

KalVista Pharmaceuticals KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral plasma kallikrein inhibitors. Its products include KVD001, a plasma kallikrein inhibitor that completed ... KALV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT